Genomma Lab Internacional
Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
DitchCarbon Score
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genomma Lab Internacional's score of 15 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genomma Lab Internacional's reported carbon emissions
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 44,075,120 kg CO2e, with 3,100,840 kg CO2e from Scope 1, 4,740,490 kg CO2e from Scope 2, and the remainder from Scope 3 emissions. This marked a significant increase in emissions compared to previous years, reflecting the company's operational scale and activities. In 2022, the company recorded total emissions of about 43,466,980 kg CO2e, with Scope 1 emissions at 2,737,470 kg CO2e and Scope 2 emissions at 4,041,110 kg CO2e. The Scope 3 emissions were notably high, indicating substantial indirect emissions from sources such as employee commuting and purchased goods and services. Genomma Lab has not publicly disclosed specific reduction targets or initiatives aimed at decreasing its carbon footprint. However, the company has been actively monitoring its emissions across all three scopes, which is essential for understanding and managing its environmental impact. The absence of formal reduction commitments suggests a potential area for improvement in their sustainability strategy. Overall, while Genomma Lab Internacional has made strides in tracking its emissions, the lack of defined reduction targets may hinder its ability to effectively address climate change challenges in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 198,500 | 000,000 | 00,000 | 000,000 | 0,000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 570,700 | 000,000 | 000,000 | 0,000,000 | - | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000 | 000,000 | - | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomma Lab Internacional is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
